Bouter, K. E. C. (2021). Therapeutic targets in type 2 diabetes and metabolic syndrome: From microbiome to medication. [Thesis, fully internal, Universiteit van Amsterdam].
van den Boogert, M. A. W. (2020). Glycosylation defects in lipid metabolism. [Thesis, fully internal, Universiteit van Amsterdam].
Surendran, R. P. (2019). Molecular metabolism underlying hypertriglyceridemia: From bench to bedside. [Thesis, fully internal, Universiteit van Amsterdam].
Udayappan, S. D. (2018). Gut microbiota in relation to pathogenesis of obesity and type 2 diabetes. [Thesis, fully internal, Universiteit van Amsterdam].
Kootte, R. S. (2018). The role of the intestine in human glucose and lipid metabolism: Source for novel targets in the prevention of cardiometabolic disease. [Thesis, fully internal, Universiteit van Amsterdam].
van Capelleveen, J. C. (2017). Identification and targeting of genes in atherosclerosis. [Thesis, fully internal, Universiteit van Amsterdam].
Bernelot Moens, S. J. (2016). Cardiovascular disease beyond traditional risk factors; balancing lipids and inflammation. [Thesis, fully internal, Universiteit van Amsterdam].
Maiwald, S. (2015). Rare genetic variants associated with early onset CVD. [Thesis, fully internal, Universiteit van Amsterdam].
Mooij, H. L. (2015). Functional consequences of inborn and acquired errors in endothelial glycocalyx heparan sulfates. [Thesis, fully internal, Universiteit van Amsterdam].
Hassing, H. C. (2013). Glycobiology in cardiometabolic homeostasis. [Thesis, fully internal, Universiteit van Amsterdam].
